AU2014352830B2 - Substituted (4'-hydroxyphenyl)cycloalkane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform - Google Patents

Substituted (4'-hydroxyphenyl)cycloalkane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform Download PDF

Info

Publication number
AU2014352830B2
AU2014352830B2 AU2014352830A AU2014352830A AU2014352830B2 AU 2014352830 B2 AU2014352830 B2 AU 2014352830B2 AU 2014352830 A AU2014352830 A AU 2014352830A AU 2014352830 A AU2014352830 A AU 2014352830A AU 2014352830 B2 AU2014352830 B2 AU 2014352830B2
Authority
AU
Australia
Prior art keywords
compounds
erp
era
agonist
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014352830A
Other languages
English (en)
Other versions
AU2014352830A1 (en
Inventor
William A. DONALDSON
Terrence S. NEUMANN
Daniel S. Sem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marquette University
Concordia University Inc
Original Assignee
Marquette University
Concordia University Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marquette University, Concordia University Inc filed Critical Marquette University
Publication of AU2014352830A1 publication Critical patent/AU2014352830A1/en
Assigned to MARQUETTE UNIVERSITY, CONCORDIA UNIVERSITY, INC. reassignment MARQUETTE UNIVERSITY Alteration of Name(s) of Applicant(s) under S113 Assignors: CONCORDIA UNIVERSITY WISCONSIN, MARQUETTE UNIVERSITY
Application granted granted Critical
Publication of AU2014352830B2 publication Critical patent/AU2014352830B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/54—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2014352830A 2013-11-21 2014-11-21 Substituted (4'-hydroxyphenyl)cycloalkane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform Active AU2014352830B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361963031P 2013-11-21 2013-11-21
US61/963,031 2013-11-21
PCT/US2014/066896 WO2015077611A1 (en) 2013-11-21 2014-11-21 Substituted (4'-hydroxyphenyl)cycloalkane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform

Publications (2)

Publication Number Publication Date
AU2014352830A1 AU2014352830A1 (en) 2016-07-07
AU2014352830B2 true AU2014352830B2 (en) 2018-12-13

Family

ID=53180206

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014352830A Active AU2014352830B2 (en) 2013-11-21 2014-11-21 Substituted (4'-hydroxyphenyl)cycloalkane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform

Country Status (6)

Country Link
US (1) US10570077B2 (enExample)
EP (1) EP3071541B1 (enExample)
JP (1) JP6431538B2 (enExample)
AU (1) AU2014352830B2 (enExample)
CA (1) CA2931313C (enExample)
WO (1) WO2015077611A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018183800A1 (en) * 2017-03-30 2018-10-04 Marquette University Substituted (4'-hydroxyphenyl)cycloalkane and (4'-hydroxyphenyl)cycloalkene compounds and uses thereof as selective agonists of the estrogen receptor beta isoform for enhanced memory consolidation
CN112341320A (zh) * 2020-11-02 2021-02-09 烟台丰鲁精细化工有限责任公司 一种对（反式-4-羟基环己基）酚的新型合成方法

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1086530A (en) * 1965-08-04 1967-10-11 Du Pont 4-phenyl and 4-substituted phenyl bicyclo[2,2,2]octane-amines
US3564060A (en) * 1967-12-08 1971-02-16 Du Pont Pharmaceutically active derivatives of 4 - phenyl - bicyclo (2,2,2)octane and oct-2-ene-1-carbinols and carboxaldehydes
US6107299A (en) * 1998-05-20 2000-08-22 Hoechst Schering Agrevo Gmbh Substituted pyridine and pyrimidine, processes for their preparation and their use as pesticides
WO2009081195A1 (en) * 2007-12-20 2009-07-02 Astrazeneca Ab Carbamoyl compounds as dgat1 inhibitors 190
WO2010086551A1 (fr) * 2009-01-28 2010-08-05 Sanofi-Aventis Dérivés de thiadiazoles et d'oxadiazoles, leur préparation et leur application en thérapeutique
US20120149807A1 (en) * 2009-09-03 2012-06-14 Sumitomo Chemical Company, Limited Diepoxy compound, process for producing same, and composition containing the diepoxy compound
WO2012112364A1 (en) * 2011-02-14 2012-08-23 Merck Sharp & Dohme Corp. Lactam derivatives as dgat-1 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4035961A1 (de) 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US6288050B1 (en) 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
AU2001255620A1 (en) 2000-04-26 2001-11-07 Warner-Lambert Company Cyclohexylamine derivative as subtype selective NMDA receptor antagonists
US8367665B2 (en) * 2008-04-16 2013-02-05 Karo Bio Ab Estrogen receptor ligands
WO2013119040A1 (en) * 2012-02-07 2013-08-15 Kainos Medicine, Inc. Compounds as inhibitors of diacylglycerol o-acyltransferase type 1 enzyme

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1086530A (en) * 1965-08-04 1967-10-11 Du Pont 4-phenyl and 4-substituted phenyl bicyclo[2,2,2]octane-amines
US3564060A (en) * 1967-12-08 1971-02-16 Du Pont Pharmaceutically active derivatives of 4 - phenyl - bicyclo (2,2,2)octane and oct-2-ene-1-carbinols and carboxaldehydes
US6107299A (en) * 1998-05-20 2000-08-22 Hoechst Schering Agrevo Gmbh Substituted pyridine and pyrimidine, processes for their preparation and their use as pesticides
WO2009081195A1 (en) * 2007-12-20 2009-07-02 Astrazeneca Ab Carbamoyl compounds as dgat1 inhibitors 190
WO2010086551A1 (fr) * 2009-01-28 2010-08-05 Sanofi-Aventis Dérivés de thiadiazoles et d'oxadiazoles, leur préparation et leur application en thérapeutique
US20120149807A1 (en) * 2009-09-03 2012-06-14 Sumitomo Chemical Company, Limited Diepoxy compound, process for producing same, and composition containing the diepoxy compound
WO2012112364A1 (en) * 2011-02-14 2012-08-23 Merck Sharp & Dohme Corp. Lactam derivatives as dgat-1 inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PANDEY, RAJESH K. ET AL., "Reactivity of (2-Alkenyl-3-pentene-1,5-diyl)iron Complexes: Preparation of Functionalized Vinylcyclopropanes and Cycloheptadienes", J. ORG. CHEM., (2008), vol. 73, pages 7236 - 7245 *

Also Published As

Publication number Publication date
AU2014352830A1 (en) 2016-07-07
JP2017504567A (ja) 2017-02-09
EP3071541B1 (en) 2023-06-07
CA2931313A1 (en) 2015-05-28
EP3071541A4 (en) 2017-07-19
JP6431538B2 (ja) 2018-11-28
WO2015077611A1 (en) 2015-05-28
US20160340279A1 (en) 2016-11-24
US10570077B2 (en) 2020-02-25
EP3071541A1 (en) 2016-09-28
CA2931313C (en) 2022-04-05

Similar Documents

Publication Publication Date Title
JP5203712B2 (ja) 選択的アンドロゲン受容体モジュレータとしてのアミノフェニル誘導体
Tao et al. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease
Schmidt et al. De novo design, synthesis, and evaluation of novel nonsteroidal phenanthrene ligands for the estrogen receptor
WO1996006081A1 (en) Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydrophenyl)-2-(piperidinyl-1)-alkanol derivatives
Shit et al. Synthesis of Spiro [furan-2, 1′-isoindolin]-3′-ones from 2-(4-Hydroxybut-1-yn-1-yl) benzonitriles and Aryl Aldehydes under the Action of Triflic Acid
US20240327421A1 (en) Substituted (4-Hydroxyphenyl)Cycloalkane and (4-Hydroxyphenyl)Cycloalkene Compounds and Uses Thereof as Selective Agonists of the Estrogen Receptor Beta Isoform for Enhanced Memory Consolidation
US20060173037A1 (en) Aminophenyl derivatives as selective androgen receptor modulators
JP2008515978A (ja) カンナビネルジック脂質リガンド
McCullough et al. Probing the human estrogen receptor-α binding requirements for phenolic mono-and di-hydroxyl compounds: A combined synthesis, binding and docking study
US10570077B2 (en) Substituted (4'-hydroxyphenyl)cyclohexane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform
Avula et al. Synthesis and antidepressant-like effects of new 5-epi-incensole and 5-epi-incensole acetate in chronic unpredictable mild stress model of depression; behavioural and biochemical correlates
US9532983B2 (en) Benzofuran compounds, compositions, kits and/or methods thereof
WO2002058639A2 (en) Pyranoflavonoid compounds and their use as estrogen receptor modulators
US20240351965A1 (en) Synthesis and Evaluation of Novel (4-Hydroxyphenyl) Substituted Carbocycles as Potent and Selective Estrogen Receptor Beta Agonists
US20110118225A1 (en) Ligands of Estrogen Receptors alpha and beta, Method of Their Preparation, and Pharmaceuticals Comprising Them
Li et al. Design, synthesis and biological evaluation of donepezil-safinamide hybrids as dual AChE and MAO-B inhibitor for Alzheimer’s disease treatment
KR102534043B1 (ko) Cns 장애의 치료에서 사용하기 위한 3.알파.-에타인일, 3.베타.-하이드록시-5.알파.-프레그난-20-옥심
Maschinot Modulation of the Hedgehog Signaling Pathway by Sterol-based Small Molecules
KR101634758B1 (ko) 에스트로겐 수용체 리간드로서의 2-하이드록시-7-메틸 옥타하이드로페난트렌 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 약학 조성물
Lu Novel cannabinergic agents and molecular probes

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: CONCORDIA UNIVERSITY, INC.

Free format text: FORMER NAME(S): CONCORDIA UNIVERSITY WISCONSIN; MARQUETTE UNIVERSITY

Owner name: MARQUETTE UNIVERSITY

Free format text: FORMER NAME(S): CONCORDIA UNIVERSITY WISCONSIN; MARQUETTE UNIVERSITY

FGA Letters patent sealed or granted (standard patent)